ESPRCEngineering and Physical Sciences Research Council (UK)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Cost-effectiveness of prostate cancer screening: A simulation study based on ESPRC data.
GS is grateful to ESPRC for financial support through the summer bursary scheme.
data, however, shows that 22% of men with a tPSA in the range 2.6-4 ng/mL harbor significant PCa, the majority of which are pathologically organ-confined and, hence, curable.(28) This finding is supported by the European screening study for PCa (ESPRC), which has reported a PCa detection rate of 19% for tPSA concentrations of 2.0-3.9 ng/mL (29) with an 84% incidence of organ-confined cancers, as opposed to 62% organ-confined PCa for total PSA of 4-10 ng/mL.
Current projects are sponsored by the Engineering and Physical Sciences Research Council (ESPRC), the EU, via the N.